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Abstract
Meesmann epithelial corneal dystrophy (MECD) is a rare autosomal dominant disorder caused by dominant-negative
mutations within the KRT3 or KRT12 genes, which encode the cytoskeletal protein keratins K3 and K12, respectively.
To investigate the pathomechanism of this disease, we generated and phenotypically characterized a novel knock-in
humanized mouse model carrying the severe, MECD-associated, K12-Leu132Pro mutation. Although no overt changes in
corneal opacity were detected by slit-lamp examination, the corneas of homozygous mutant mice exhibited histological
and ultrastructural epithelial cell fragility phenotypes. An altered keratin expression proﬁle was observed in the cornea of
mutant mice, conﬁrmed by western blot, RNA-seq and quantitative real-time polymerase chain reaction. Mass spectrometry
(MS) and immunohistochemistry demonstrated a similarly altered keratin proﬁle in corneal tissue from a K12-Leu132Pro
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MECD patient. The K12-Leu132Pro mutation results in cytoplasmic keratin aggregates. RNA-seq analysis revealed increased
chaperone gene expression, and apoptotic unfolded protein response (UPR) markers, CHOP and Caspase 12, were also
increased in the MECD mice. Corneal epithelial cell apoptosis was increased 17-fold in the mutant cornea, compared with
the wild-type (P < 0.001). This elevation of UPR marker expression was also observed in the human MECD cornea. This is the
ﬁrst reporting of a mouse model for MECD that recapitulates the human disease and is a valuable resource in understanding
the pathomechanism of the disease. Although the most severe phenotype is observed in the homozygous mice, this
model will still provide a test-bed for therapies not only for corneal dystrophies but also for other keratinopathies caused
by similar mutations.
Introduction
Corneal dystrophies are a group of blinding heritable conditions,
with a prevalence of approximately one in 2000 (1). They are non-
inﬂammatory conditions restricted to the cornea and usually
result in a loss of corneal transparency (2). They have been clas-
siﬁed into four separate anatomically deﬁned groups: epithelial
and subepithelial dystrophies, epithelial–stromal transforming
growth factor beta-induced (TGFBI) dystrophies, stromal dystro-
phies and endothelial dystrophies (3). Genetic analysis of familial
cases has revealed corneal dystrophicmutations arising in TGFBI,
KRT3, KRT12, TACSTD2, CHST6, UBIAD1, DCN, PIKFYVE, COL8A2,
COL17A1, ZEB1 and SLC4A11 genes (3,4).
Meesmann epithelial corneal dystrophy (MECD) is a rare auto-
somal dominant hereditary disorder of the anterior corneal epi-
thelium. Typically, MECD is characterized by intra-epithelial
microcysts in the central cornea, with occasional cases exhibiting
grey serpiginous lines. In most cases, MECD remains asymptom-
atic and is only detected in routine eye tests. However, it can be-
come more debilitating with some individuals experiencing
photophobia, blurred vision or foreign body sensation with rup-
ture of epithelial cysts at the corneal surface. MECD is caused
by heterozygous mutations in either the KRT3 or KRT12 genes,
which encode corneal-speciﬁc keratins K3 and K12, respectively
(5,6). These form K3–K12 heterodimers that polymerize to form
the intermediate cytoskeletal ﬁlaments that provide structure
and stability to corneal epithelial cells (7,8). Twenty-three muta-
tions in KRT12 and three in KRT3 have been reported to cause
MECD of variable severity (www.interﬁl.org, October 2015, date
last accessed). Apart from one small in-frame insertion, all of
the causative variants are missense and are known to exert a
dominant-negative effect (6). All mutations are located in the
functionally critical helix initiation or helix termination motifs,
indicating that protein misfolding plays a role in MECD (9). How-
ever, the mechanism by which K12 mutations cause corneal
microcyst formation and cytolysis remains poorly understood.
The unfolded protein response (UPR) is a pathway stimulated
to respond to an accumulation of misfolded or mutant proteins
within the endoplasmic reticulum (ER) (10). Proteins such as cha-
perones and ER-associated degradation components are recruited
to placate cellular protein translation (11). However, prolonged in-
ductionof theUPR because of continuous expression andmisfold-
ing of mutant protein can lead to apoptosis (10). This occurs in a
variety of conditions with a genetic basis, including Alzheimer
disease (12) and cystic ﬁbrosis (13). The induction of cellular stres-
ses in corneal disorders is not uncommon. UPR pathways have
previously been shown to be induced in Fuchs endothelial corneal
dystrophy (14–16) and in the formation of cataracts (17). Members
of the keratin family of proteins have also been implicated in cel-
lular stress responses, ranging fromapoptotic stress and oxidative
stress to wound healing and tissue repair (18,19).
To study the mechanisms of corneal fragility and cytolysis as-
sociated withMECD-causing keratin K12mutations, we generated
a targeted humanized knock-inmousemodel of MECD and inves-
tigated the corneal phenotypes that developed. Although K12-
Arg135Thr is the most common MECD-causing mutation found
in the European population (5), the most severe phenotype has
been observed in patients with the K12-Leu132Pro mutation. In
these patients, subepithelial basement membrane scarring and
central corneal opaciﬁcation can result in blindness. Furthermore,
the K12-Leu132Pro protein more readily forms aggregates than
K12-Arg135Thr protein (20). Therefore, mice were generated with
the humanmutant KRT12 allele carrying the Leu132Promutation,
and a C-terminal Flag-HA epitope tag, into the mouse Krt12 locus
by homologous recombination. Histological analysis of the cor-
neaswas performed to ascertain any irregularities in the structure
of the cornea, whereas immunohistochemistry (IHC) was used to
visualize keratin expression proﬁles and assess the expression of
UPRmarkers. These expression proﬁles were also assessed in cor-
neal tissue from a K12-Leu132Pro MECD patient. A proteomic ana-
lysis was also performed on the human MECD cornea, and
compared with control corneal tissue, to ascertain the presence
of keratin dysregulation in the human phenotype.
Results
Generation of humanized KRT12 mutant knock-in mice
A targeting vector was generated that contained the full human
KRT12 gene including introns, untranslated regions (UTRs) and a
247 bp sequence downstream of the KRT12 3′-UTR. Exon 1 carried
the L132P mutation, and a FLAG-HA coding sequence (21) was
placed immediately before the termination codon. A multiple tar-
geting cassette (MTC) was inserted into the KRT12 3′-UTR, consist-
ing of target sequences for four MECD mutations (Supplementary
Material, Fig. S1). The targeting strategy is shown in Figure 1. This
targeting vector was used to introduce the human Leu132Pro
KRT12mutant allele (KRT12-L132P) into the murine Krt12 locus by
homologous recombination in mouse embryonic stem cells,
which were used to generate transgenic mice on the C57BL/6 back-
ground (Fig. 1). Germline transmission of the targeted allele was
conﬁrmed by polymerase chain reaction (PCR) (Supplementary
Material, Fig. S4), and recombinant mutant mice were bred with
transgenic C57BL/6 mice universally expressing Flp-deleter recom-
binase to excise theNeoRandPuroRcassettes (Fig. 1) (22). The result-
ant KRT12-L132P-positive, NeoR/PuroR-negative mouse line was
designated Krt12hL132P. Heterozygous (Krt12+/hL132P) and homozy-
gous (Krt12hL132P/hL132P) mutant mice were viable and fertile with
no superﬁcial corneal abnormalities (data not shown).
Characterization of heterozygous (Krt12+/hL132P) and
homozygous (Krt12hL132P/hL132P) corneal epithelium
Mice of each genotype [wild-type (WT), heterozygous, homozy-
gous; n = 6] were assessed for gross changes in corneal morph-
ology by slit-lamp evaluation at 8, 12, 16 and 30 weeks. No
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differences were observed with respect to the clarity of the cor-
nea between the genotypes (Supplementary Material, Fig. S2A).
Additionally, at 16 weeks, mouse eyes were observed following
ﬂuorescein staining to highlight areas of damage or abnormality
on the corneal surface. Again, no overt differences were observed
between the genotypes (Supplementary Material, Fig. S2B).
Histology and electron microscopy of Krt12+/hL132P
and Krt12hL132P/hL132P corneal epithelium
Whole eyes were harvested from mice (n = 3 per genotype) at 8,
16 and 24 weeks. The observed histology did not change signiﬁ-
cantly over time and representative images of 8-week-old mice
are shown (Fig. 2). The corneal epithelium ofWTanimals showed
a close packed, regular cell structure; however, the corneal epi-
thelial cells of homozygous mutant mice were highly disorga-
nized (Fig. 2A). Additionally, although the number of cell layers
was the same for each genotype, the corneal epithelium was
∼50% thicker in homozygous mutant animals (Fig. 2A). Mutant
cells were larger, contained prominent intracellular spaces and
showed overt cytolysis with occasional cell rupture at the corneal
surface. Delaminations at the basal layer in the homozygous an-
imals were also observed, reminiscent of structural defects seen
in the K12 null mouse (23). Defects in heterozygous mice were
very subtle; however, intracellular spaces were clearly increased.
Additionally, no cytolysis or delamination of the corneal epithe-
lial interface was observed in heterozygous mice (Fig. 2A).
The corneal surfaces of 7-week-old mice (n = 1 per genotype)
were examined by scanning electron microscopy (SEM). Slough-
ing of terminally differentiated epithelial cells was observed in
all genotypes. However, no corneal surface defectswere observed
in mutant mice (Fig. 2B). These corneas were also evaluated by
transmission electron microscopy (TEM). WT corneal keratino-
cytes showed normal cellular structure. In contrast, keratino-
cytes from homozygous mutant mice showed cytoplasmic
vacuoles and other defects suggestive of cell fragility (Fig. 2C),
with similar but subtle changes present in heterozygous mice.
IHC analysis of transgene expression
The humanized KRT12-L132P transgene has a C-terminal FLAG-
HA epitope tag, which enabled IHC conﬁrmation of transgene ex-
pression and translation in heterozygous and homozygous mice
(Fig. 3). Expression was speciﬁc to the corneal epithelium and ob-
served in all epithelial layersmoving centrally from the limbal re-
gion. Western blotting conﬁrmed transgene expression in
heterozygous and homozygous animals (Fig. 3).
Gene expression analysis in Krt12hL132P mouse cornea
mRNA fromWT, heterozygous and homozygous Krt12hL132P mu-
tant mice was isolated frommouse corneas (n = 6 per group) and
gene expression quantiﬁed by RNA-seq analysis. Sequencing
data were analysed by comparing mRNA expression in the cor-
nea of heterozygote or homozygotemutantmice to theWT refer-
ence (n = 6 corneas per group). The genes with statistically
signiﬁcant changes in expression, adjusted for false discovery
rate (P < 0.05), were determined. The most dysregulated genes,
with respect to the WT, in the heterozygous (two genes) and
homozygous mutant (25 genes) mice were tabulated and sorted
by fold change (Supplementary Material, Table S1). Ten of the
most highly upregulated genes were lens crystallins, which
showed increases in expression between 8.4- and 520-fold. In
the homozygous Krt12hL132P/hL132P cornea, the expression of 11
keratin genes was upregulated (Fig. 4). These data were veriﬁed
by quantitative real-time (qRT)-PCR (Fig. 4). Krt16 was the most
highly upregulated keratin mRNA (approximately 20-fold). Krt14
was upregulated approximately 5-fold with Krt4, Krt10, Krt13
and Krt15 upregulated approximately 3-fold. Krt6a, Krt6b, Krt7,
Krt76 and Krt78 were also upregulated but to a lesser extent
(less than 2-fold). qRT-PCR analysis showed that Krt5 was down-
regulated (approximately 0.5-fold). qRT-PCR analysis of keratin
gene expression in heterozygous Krt12+/hL132P cornea showed
an alteration similar to that seen in Krt12hL132P/hL132P, with smal-
ler, but signiﬁcant, alterations in expressions of Krt4, Krt5, Krt6b,
Krt7, Krt14, Krt16, Krt17 and Krt76 (0.7–9-fold) (Fig. 4).
Figure 1.Generation of a humanizedmutant K12mousemodel. The endogenousmouse Krt12 gene in its genomic context (A) was targeted for homologous recombination
byavector incorporating thehumanKRT12 gene (B). The targeting vector contained twohomologyarms (LHAandSHA) for targeted replacement of the endogenousmouse
Krt12with the humanized genomic region. The human allele includes all UTRs, exons and introns with additional coding for a FLAG-HA tag immediately prior to the stop
codon and a single nucleotide change in exon 1 creating the L132Pmutant (B). Additionally, anMTC is included within the 3′-UTR. FRT- and F3-ﬂanked selectionmarkers
were includedwithin introns 2 and 7 to assist in the selection of cloneswhere the transgene had been correctly targeted (C). Transgene-positivemicewereﬁnally interbred
with transgenic mice universally expressing Flp recombinase to excise the selection markers (D). Krt20 and LOC are neighbouring genes.
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IHC analysis of corneal keratin protein expression
patterns
To verify the altered keratin expression observed by RNA-seq and
qRT-PCR analyses, corneal keratin expression was assessed by
IHC (n = 2 per genotype at 8, 12 and 16 weeks; Fig. 5A) and vali-
dated by western blotting (Fig. 5B; n = 3 per genotype, mice aged
7–9 weeks). Figure 5A shows representative IHC data from 8-
week-oldmice, in which keratin expression changes were clearly
observed. Identical results were obtained at the other time points
(data not shown). With no murine equivalent to K3, K5 has been
shown to be the endogenous polymerization partner of K12 in
murine cornea (7). Immunohistological analysis revealed K5 to
be present within all layers of the cornea in all genotypes. How-
ever, western blot analysis, in agreement with the qRT-PCR data,
showed that K5 abundance decreased proportionally with re-
duced WT mK12 expression, with K5 expression in homozygous
Figure 2.Microscopic assessment of MECDmouse corneas. (A) Representative images of H&E-stained 8-week-old mice corneas. WT mice typically have a tightly packed
corneal epithelium, with subtle small intracellular spaces occasionally visible in the heterozygous mice (white arrows). Homozygous mutant mice exhibited greater
phenotypic changes, with cells less tightly packed and with large intracellular spaces leading to cytolysis (asterisks); delamination of the corneal epithelium at the
stromal interface (black arrows) was observed in the homozygous mutant mice. Scale bar = 100 µm. (B) SEM micrographs of the corneal surface (n = 1 per genotype,
both eyes) show squames ﬂaking or beginning to ﬂake off; however, no signiﬁcant differences were observed on the corneal surface between genotypes (scale bar,
50 µm). (C) TEM micrographs of the basal layer cells of each genotype (25 000× magniﬁcation) show the stroma (black asterisks) and nuclei (white asterisks). WT cells
appear to have a more distinct structure with tight cell–cell interfaces in comparison to homozygous mutant cells. Vacuoles and structures associated with
mechanical weakness (white arrows) are observed in these cells. The corneas of heterozygous mutant more closely resembled those of the WT mice; however, some
evidence of an increase in vacuolization was noted (white arrows).
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mutantmice less than half that of theWTmouse (P < 0.05; Fig. 5B
and Supplementary Material, Fig. S3).
The heterodimeric partner of K5 in skin is K14, in both hu-
mans and mice (24). In response to reduced mK12 expression,
K14 mRNA expression was strongly upregulated in homozygous
mutant animals, with an approximate 19-fold increase in protein
expression observed by western blot analysis of homozygous
mutant mouse corneas (P < 0.05; Fig. 5B and Supplementary
Material, Fig. S3).
K6 was found in the upper suprabasal layers of WT mice
(Fig. 5A), and its expressionwas greatly increased in homozygous
mutantmice andwas conﬁrmed bywestern blot analysis with an
approximate 1.5-fold increase (P < 0.05; Fig. 5B and Supple-
mentary Material, Fig. S3). IHC and western blot analyses also
showed that expression of K16, a heterodimeric partner of K6,
was upregulated by almost 1000-fold in homozygous mutant
mice (P < 0.05). Additionally, no expression of the conjunctival
keratins K8 and K19 was observed in the corneal epithelium of
any of the genotypes (data not shown).
Histological and immunohistological examination
of human Leu132Pro KRT12 MECD corneal tissue
To examine whether the changes in the keratin expression
proﬁle seen in the mouse model reﬂect changes seen in human
MECD cornea, a histological and IHC analysis was performed
on a cornea obtained, following corneal graft surgery, from an
MECD patient with the same heterozygous Leu132Pro KRT12
mutation.
Histology of the MECD cornea revealed characteristic disor-
ganization of the corneal epithelium and a pronounced thicken-
ing of Bowman’s layer in comparison to the healthy control
tissue (Fig. 6, black arrow). The appearance of microcysts and
intra-cytoplasmic vacuoles, similar to those previously reported
inMECD corneal tissue (5) (Fig. 6, represented by an asterisk), was
also noted. IHC analysis of keratin expression revealed patterns
of altered expression in the human MECD corneal epithelium
similar to those observed in the MECD mouse model, with in-
creased expressions of K6, K14 and K16. In contrast to the
mouse, and perhaps reﬂecting that in humans the heterodimeric
partner of K12 is K3, K5 expression is increased in parallel to its
human heterodimeric partner, K14 (Fig. 6). IHC also revealed a re-
duced expression in K12 in the MECD cornea, in comparison to
the control healthy corneal tissue.
Determination of the MECD corneal proteome
To further characterize the changes in protein expression occur-
ring in the cornea of MECD patients, we undertook an analysis of
the corneal proteome of one MECD patient using liquid chroma-
tography–tandem MS.
Upon assessment of the healthy corneal tissue andMECD cor-
neal tissue, a list of the most abundant proteins present within
each tissue was constructed and their relative abundances
Figure 3. Veriﬁcation of KRT12 transgene expression. (A) The KRT12 transgene has a C-terminal FLAG-HA epitope tag. The HA epitope is present only in the heterozygous
and homozygous mutant mice (brown staining). Staining was observed in all epithelial layers moving centrally and inward from the limbal region (scale bar, 100 µm).
(B) Corneal protein lysates from 7 to 9-week-old mice (n = 3 per genotype) were simultaneously probed for K12 and HA. Only mK12 was observed in corneas from WT
mice (green lower band), whereas only the HA-tagged protein (green hK12 and red HA co-localize for a yellow merged image) was present in homozygous mutant
mice. Both proteins were present in heterozygous mice. β-actin was used as a loading control.
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calculated. Proteins were displayed as theirmolar percentagewith-
in the sample (Supplementary Material, Table S2), and the 25 most
abundant proteins in each tissue determined (Table 1). Reﬂecting
that this analysis represented the proteome of the whole cornea,
the expression proﬁles of the normal and diseased corneas were
broadly similar, with the expression of stromal extracellular matrix
proteins such as collagens [alpha-1(I), alpha-2(I), alpha-1(IV) and
alpha-3(VI)], proteoglycans (keratocan, decorin and lumican) and
Figure 4.Differential expression of keratinmRNA inMECDmouse corneas. qRT-PCR validation of keratinmRNA levels obtained by RNA-seq. Fold change in expression for
each keratin was calculated by normalization to that observed in theWTmouse cornea. Similar expression levels were observed for RNA-seq and qRT-PCR in all keratins
analysed except KRT10 andKRT17, inwhich greater expressionwas found inheterozygous andhomozygousmice by qRT-PCR,whereas RNA-seq deemed these keratins to
be comparably expressed in all three genotypes.
Figure 5. Differential expression of keratins in MECD mouse cornea. (A) Representative pictures of IHC staining (brown, nuclei blue) of the central corneas of 8-week-old
mice are shown. K5 was present throughout all layers of the corneal epithelium in all genotypes. Expression of K14 was markedly increased in the homozygous animals.
K6 was found in the outer layer of all corneas with staining signiﬁcantly increased in the homozygousmutant; K16was also strongly upregulated in homozygousmutant
mice. Scale bar, 100 µm. (B) Immunoblotting of corneal lysates (n = 3 per genotype) for keratins K5, K14, K6, K16 and K13, normalized to β-actin. K5 levels were greatly
reduced when WT and heterozygous mice and heterozygous and homozygous mutant animals are compared. K14 was strongly upregulated in homozygous mouse
cornea, with a small change in heterozygous mice. K6 increased with increasing transgene expression when WT and homozygous mice are compared. Similar
changes in expression pattern were observed with K16 and K13.
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corneal epithelial chaperone proteins (aldehyde dehydrogenase)
unaltered. Notably, and in agreement with the IHC analysis, there
were increases in the relative abundance of keratins K5, K14, K6A
and K13 (Table 2). However, an increase in K12 was also found, in
contrast to that observed by IHC of the human MECD cornea.
UPR activation and apoptosis in the Krt12+/hL132P
and Krt12hL132P/hL132P corneal epithelium
Missensemutations in Krt12 have been demonstrated to result in
the accumulation of protein aggregates in corneal epithelial cells,
presumably due to protein misfolding (20,25). Accumulation of
misfolded or mutant proteins within both the cytoplasm and
the ER stimulates theUPR,which, if it fails to resolve the ER stress,
may in turn lead to increased apoptosis (15).
We sought to determinewhether expression of mutant K12 in
corneal epithelial cells activated the UPR pathway and apoptosis.
ER stress-driven stimulation of the UPR is associated with the in-
duction of CCAAT/enhancer-binding protein homologous protein
(CHOP) expression (26). IHC analysis of corneal sections from 24-
week-old WT, heterozygous and homozygous mutant mice
showed that expression of CHOP was upregulated in the corneal
epithelium of homozygous Krt12hL132P/hL132P mice but not in ei-
ther heterozygous Krt12+/hL132P or WT Krt12+/+ mice (Fig. 7A).
Failure of the UPR to resolve ER stress results in the stimula-
tion of caspase-mediated apoptotic pathways (27,28). We investi-
gated the induction of Caspase 12, as this protein has previously
been shown to be activated during UPR-induced apoptosis in a
corneal dystrophy mouse model (15). IHC analysis showed up-
regulation of Caspase 12 in the cornea of homozygous
Krt12hL132P/hL132P mice and, to a lesser extent, in heterozygous
Krt12+/hL132P mice at 24 weeks of age, but not in WT Krt12+/+
mice (Fig. 7A).
Analysis of corneal sections using a terminal deoxynucleotidyl
transferase dUTP nick end labelling (TUNEL) assay (29) showed in-
creased apoptosis in the corneas of homozygous Krt12hL132P/hL132P
mice at 24 weeks of agewhen compared with either heterozygous
Krt12+/hL132P or WT Krt12+/+ mice (Fig. 7B). The cellularity and
apoptotic rate observed incorneal epithelial cellswere quantitated
(Fig. 7B). The average number of live cells/ﬁeld-of-vision for WT,
heterozygous andhomozygousmicewas 80, 91 and 80, respective-
ly, with no signiﬁcant difference between any of the genotypes.
However, the average rate of apoptosis was signiﬁcantly increased
(P < 0.001) in homozygous Krt12hL132P/hL132P mice (48.1 ± 6.64%)
compared with either heterozygous Krt12+/hL132P (2.8 ± 1.32%) or
WT Krt12+/+ mice (2.8 ± 1.47%) (Fig. 7B). These results suggest that
the UPR is able to resolve the ER stress induced by mutant L132P
K12 in the heterozygous Krt12+/hL132P mice but not in the homozy-
gous Krt12hL132P/hL132P mice.
UPR in the MECD human cornea
To examinewhether the stimulation of the UPR and apoptosis seen
in the mouse model reﬂect changes seen in human MECD cornea,
IHC and TUNEL analyses were performed on a cornea obtained
from an MECD patient heterozygous for the dominant-negative
Figure 6.Differential expression of keratins in the humanMECD corneal epithelium. Histological assessment of the humanMECD cornea demonstrated a loss in epithelial
organization in comparison to the healthy unaffected cornea. Sections from both corneas were also assessed by IHC for the expressions of K12, K5, K14, K6A and K16
(green). Nuclei were counterstained with DAPI (blue). The MECD tissue appeared to have a decreased abundance of K12 protein in the epithelium, compared with the
control. Expression of K5, K14, K6A and K16 was increased in the MECD cornea, compared with that found in the control cornea. Scale bar = 100 and 200 µm, left and
right images, respectively.
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L132PKRT12mutationandcompared toacorneafromanunaffected
donoreye.Althoughnoexpressionof eitherCHOPorCaspase12was
observed in the unaffected cornea, expression of both was found in
the corneal epithelium of the MECD cornea (Fig. 7C), suggesting an
upregulation of the UPR. Although a small number of apoptotic
cells was observed by TUNEL staining of the human MECD corneal
section, andnone in theunaffected cornea (Fig. 7C), cornealmaterial
from additional MECD patients was unavailable to determine
whether this difference was statistically signiﬁcant.
Discussion
We have generated a mouse model for MECD and demonstrated
that replacement of theWTmouse Krt12 allelewith of the human
KRT12-Leu132Pro mutant allele results in a corneal phenotype
that closely resembles that of MECD patients heterozygous for
mutation in KRT12 (2,9,20). These patients were described to
have opacities in the corneal epithelium caused by intra-epithe-
lial cysts. This model demonstrates that the KRT12 Leu132Pro
mutation results in a disorganized corneal epithelium with cell
fragility, delamination of the basal layer and overt cytolysis gen-
erating cysts that occasionally rupture at the corneal surface.
This is the ﬁrst MECD model to carry a mutation within the
KRT12 gene that is known to cause MECD in man and as such
will provide an in vivomodel in which to test potential therapies
for epithelial corneal dystrophies.
Two mouse models of altered Krt12 have been reported, and
neither presents with a phenotype that closely matches that of
MECD. A Krt12 knock-out mouse has been developed, in which
heterozygousmutant mice have a normal phenotype and homo-
zygous null mice exhibit corneal epithelial fragility andmild cor-
neal epithelial erosion (23). Unlike the Leu132Pro model, the
number of cell layers in the corneal epithelium of null mice is re-
duced. The superﬁcial epithelial cells of Krt12 null mice lack ker-
atin intermediate ﬁlaments and are easily detached by gentle
rubbing. The lack of severe epithelial defects such as corneal ul-
ceration and perforation in the Krt12 null mice was attributed to
the rapid replacement of lost superﬁcial epithelial cells from dee-
per layers. This may also explain the lack of a phenotype as
severe as that seen in patients with Leu132Pro KRT12 mutation
in the mice with the same mutation.
Bi-allelic expression of Krt12 and Cre recombinase in a second
mouse Krt12model was used to examine the possibility of clonal
allelic activation in corneal epithelial cells (30). Random activa-
tion of one or the other Krt12 alleles was observed during the
Table 1. Relative amounts of the 25 most abundant proteins in control and MECD human corneal tissues
Control tissue MECD tissue
Name Amount (%) Name Amount (%)
1 Serum albumin 12.28 1 Collagen alpha-1(I) chain 9.50
2 Collagen alpha-1(I) chain 10.72 2 Serum albumin 9.07
3 Collagen alpha-2(I) chain 5.32 3 Collagen alpha-2(I) chain 4.06
4 Ig kappa chain C-region 5.06 4 Ig kappa chain C-region 3.48
5 TGFBI 4.28 5 TGFBI 2.86
6 Keratocan 3.23 6 Histone H4 2.64
7 Vimentin 2.53 7 Keratin, type II cytoskeletal 5 2.61
8 Decorin 2.35 8 Keratocan 2.41
9 Ig lambda-2 chain C regions 2.33 9 Ig lambda-2 chain C regions 2.41
10 Collagen alpha-3(VI) chain 2.06 10 Histone H2B type 1-B 2.15
11 Lumican 2.02 11 Keratin, type I cytoskeletal 14 2.10
12 Aldehyde dehydrogenase, dimeric NADP-preferring 1.86 12 Lumican 2.06
13 Mimecan 1.85 13 Histone H2B type 1-C/E/F/G/I 1.93
14 Ig gamma-1 chain C-region 1.83 14 Keratin, type II cytoskeletal 6A 1.92
15 Histone H2B type 1-H 1.68 15 Collagen alpha-3(VI) chain 1.80
16 Histone H2B type 1-C/E/F/G/I 1.66 16 Decorin 1.76
17 Serotransferrin 1.38 17 Apolipoprotein A-I 1.73
18 Apolipoprotein A-I 1.25 18 Haemoglobin subunit beta 1.55
19 Histone H4 1.23 19 Ig gamma-1 chain C-region 1.52
20 Apolipoprotein A-II 1.22 20 Aldehyde dehydrogenase, dimeric NADP-preferring 1.40
21 Collagen alpha-1(VI) chain 1.14 21 Keratin, type I cytoskeletal 13 1.37
22 Prolargin 1.13 22 Apolipoprotein A-II 1.34
23 Ig kappa chain V-III region SIE 1.04 23 Collagen alpha-1(VI) chain 1.28
24 Annexin A2 0.96 24 Keratin, type I cytoskeletal 12 1.27
25 Ig gamma-3 chain C-region 0.95 25 Vimentin 1.17
A list of the top 25 proteins, by percentage abundance, found in healthy control or MECD corneal tissue was produced. Keratin proteins were only found in the 25 most
abundant proteins in the MECD corneal tissue. Results are representative of one MECD patient cornea and one healthy control patient cornea.
Table 2. Comparison of keratins with >1% abundance in control or
MECD tissue
Relative
abundance (%) Fold
changeName Control MECD
Keratin, type II cytoskeletal 5 0.53 2.61 +4.9
Keratin, type I cytoskeletal 14 0.13 2.10 +15.6
Keratin, type II cytoskeletal 6A 0.00 1.92
Keratin, type I cytoskeletal 13 0.00 1.37
Keratin, type I cytoskeletal 12 0.15 1.27 +8.4
In total, 10 keratin proteins were found across both corneal tissue samples. For
keratins with a relative abundance >1% in either tissue and found in both
tissues, the fold change in abundance between MECD and control tissues was
calculated.
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course of terminal corneal epithelial cell differentiation. The
authors suggested that this selection could be advantageous, as
it would allow the generation of cells expressing haplosufﬁcient
quantities of WT K12 in the absence of dominant-negative mu-
tant K12. However, uniform expression of HA-tagged Leu132Pro
mutant K12 protein in all cells of the corneal epithelium of
heterozygous Krt12+/hL132Pmice suggests that this is not the case.
These differences suggest that unlike the Krt12 null mouse,
our KRT12 Leu132Pro mouse appears to represent a highly rele-
vant model in which to study the pathogenesis of epithelial
Figure 7. Assessment of induction of the UPR and apoptosis in MECD mouse corneas. (A) IHC analysis of UPR markers, Caspase 12 and CHOP, was performed on corneal
sections fromWT (+/+), heterozygous (+/−) and homozygous MECD mice (green). Nuclei were counterstained with DAPI (blue). Scale bar = 100 µm. Positive staining for
both UPR markers was observed in the homozygous mouse corneal epithelium, whereas subtle staining of Caspase 12 was found in the corneal epithelium of
heterozygous mice. (B) A TUNEL assay was performed to identify the presence of apoptotic cells within the corneas of these mice (green). The number of TUNEL-
positive cells was counted to ascertain the apoptotic cells, whereas DAPI-stained cells were counted to gauge the total number of cells. A signiﬁcant increase in the
proportion of apoptotic cells was observed in homozygousmicewhen comparedwithWT,with the rate in heterozygousmice being comparable toWT. Scale bar = 100 µm.
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corneal dystrophy caused by mutations in KRT12. However, des-
pite the similarities in phenotype observed in heterozygous
MECD patients and homozygous Krt12hL132P/hL132P mice, some
differences should be noted. In contrast to the Krt12hL132P/hL132P
mice, slit-lamp photography of KRT12 Leu132Pro MECD patients
reveals, in addition to characteristic microcysts in the anterior
epithelium, an uneven corneal topography secondary to damage
and scarring of the underlying basementmembrane and anterior
stroma (20). The phenotype is even milder in the directly geno-
type comparable heterozygous Krt12+/hL132P mice.
K12 is a type I (acidic) keratin produced by differentiated cor-
neal epithelial cells that heterodimerises in a parallel, in-register
fashion with K3, a type II (basic keratin). These heterodimers
associate to form a number of species of stable tetramer, which
ultimately polymerise form the ∼10nm diameter keratin inter-
mediate ﬁlaments (31–33). The structures of both type I and
type II keratins consist of an approximately 300 amino acid cen-
tral rod domain consisting of four alpha-helical segments sepa-
rated by three ﬂexible linker domains. At the beginning of the
ﬁrst and at the end of the last helical domain are the highly con-
served approximately 20 amino acid helix initiation and termin-
ation motifs, respectively. These, in turn, are ﬂanked by the
N-terminal head and C-terminal tail domains, which are the
most divergent domains between different keratins and are
thought to confer tissue-speciﬁc functions such as interactions
with other cytoplasmic or membrane proteins. All known MECD
mutations in KRT3 and KRT12 consist of dominant-negative mis-
sense mutations (or one small in-frame insertion) that occur
in either the helix initiation or the termination motifs (www.
interﬁl.org, 15 October 2015, date last accessed) that fulﬁl a critical
role in the early stages of ﬁlament assembly (34). Mutations in
these regions in type I and type II keratins are associated with
the most severe disease phenotypes (6,35). Failure to adopt
the correct secondary or tertiary structure or to assemble into
keratin ﬁlaments is likely to result in protein misfolding and/
or aggregate formation and induction of the UPR. Formation
of keratinous cytoplasmic aggregates has been observed in
cells transfected with Leu132Pro KRT12 (20) and in transmis-
sion electron micrographs of corneal epithelial cells from an
MECD patient (25).
Although translated in the cytoplasm, accumulation of mis-
folded proteins such as keratins can induce ER stress and the
UPR (36). The ﬁrst response of cells to the accumulation of un-
folded proteins is to reduce global protein translation to reduce
the ER protein load and the upregulation of cytoplasmic molecu-
lar chaperones, such as heat shock proteins (HSPs), which act to
restore protein homeostasis (proteostasis) (10). Originally de-
scribed to maintain transparency of the lens, crystallins have a
protective inﬂuence on the cytoplasm, inhibit apoptosis and en-
hance resistance of lens cells to stress (37,38). α-Crystallins, close-
ly related to small HSPs, have been shown to act as molecular
chaperones in other cell types (38,39). Lens alpha-, beta- and
gamma-crystallins have been shown to be expressed in murine
and human corneas (40), and members of each family have
been shown to be upregulated by corneal degeneration in mice
(41). RNA-seq analysis of the corneal epithelium of homozygous
Krt12hL132P/hL132P mice revealed that crystallins represented 10 of
the most upregulated genes, suggesting a UPR in mutant corneal
epithelial cells. Similarly upregulated, SerpinB2 has been shown
to play a role in the aggregation of misfolded proteins into large
protein inclusions that are thought to be less proteotoxic than
smaller oligomeric complexes (42). In addition to their role in fa-
cilitating protein folding and assembly, chaperones have roles in
the sorting of misfolded proteins to the proteasomal and
lysosomal compartment for degradation and disposal in a pro-
cess termed chaperone-assisted autophagy. Here, cytosolic ma-
terial, such as protein aggregates, is encapsulated by a
phagophore membrane to form an autophagosome which can
fuse with the lysosome (43). Autophagy has been shown to
modulatemutant keratin 18-containing inclusion formation (44).
Failure of the adaptive UPR to restore proteostasis and relieve
ER stress in cells expressing mutant misfolded protein can over-
whelm the proteosomal and lysosomal pathways and lead to ac-
tivation of the apoptotic arm of the UPR (10). IHC demonstrated a
strong staining of UPR markers CHOP and Caspase 12 in both
mouse and human corneal tissues, with staining particularly
pronounced in the corneal epithelium. Upregulation of CHOP
and Caspase 12 results in increased apoptosis of the corneal epi-
thelial cells in homozygousmice demonstrated by the number of
TUNEL-positive cells. However, no increase in apoptosis was
seen in the heterozygous mouse or the human MECD cornea.
Although typically associated with an upregulation of apoptotic
pathways, CHOP has also been found to play a protective role to
improve protein-folding capacity and cell survival by transcrip-
tional regulation of particular target genes and microRNAs such
asGADD34 (26) andmiR-708 (45). BothGrp78 andChop are upregu-
lated in a mouse model of Fuchs endothelial corneal dystrophy
caused by dominant missense mutation of Col8a2 (46), which
results in endothelial cell apoptosis. Interestingly, lithium treat-
ment upregulated expression of autophagy markers P62,
Tmem74, Tm9sf1 and Tmem166 and improved endothelial cell sur-
vival, yet had no effect on the expression of either Grp78 or Chop,
and even increased expression of Caspase 12. This suggests that a
balance of factors ultimately determines cell fate following UPR-
induced CHOP expression. Although an alteration in expression
of stress-related genes was not observed by RNA-seq analysis,
here this may be due to an alteration in expression not large
enough to be deemed signiﬁcant with the small number of bio-
logical replicates used here. Although the proteomic analysis of
the patient cornea did not determine an extensive list of all pro-
teins found in the cornea, the most abundant proteins above the
detection threshold are listed. Therefore, it is possible that stress
proteins were differentially expressed in the human corneal
samples, but unfortunately were expressed at a level below that
quantiﬁable by the methods of detection used here.
Although there are many phenotypic similarities between
human MECD and the mouse model, some differences do exist.
A pronounced thickening of the corneal epithelium in the
MECDmousemodel was observed, which has not been described
in human MECD. The thickening of Bowman’s layer, observed in
the human MECD tissue (5), is not found in this mouse model as
the structure of the mouse cornea is somewhat different from
that of human and lacks a Bowman’s layer (47).
Expression of mutant Leu132Pro K12 results in differences in
keratin protein proﬁles in the corneal epithelium between WT
and mutant mice that largely recapitulate the changes found in
the cornea of an MECD patient with the same mutation. Expres-
sion of keratins K6 andK16,which are known to be upregulated in
response to stress (48), was observed. Although K6 is typically
found in the upper layers of the corneal epithelium (49), K16 is
usually absent but is upregulated during corneal epithelial
wound healing where normal keratin expression is also dysregu-
lated (50,51). Keratins K5 and K14 are expressed as a heterodi-
meric pair in the basal layer of the early prenatal cornea and
corneal epithelium (52), with expression of K14 decreasing as
K12 is increasingly expressed in more peripheral layers (53,54).
In the absence of sufﬁcient functional K12, K14 expression may
be upregulated in compensation or as a consequence of this.
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These keratins appear to be coordinately regulated as downregu-
lation of epithelial K12 expression seen in Pinin (Pnn)-null mice is
observed together with ectopic expression of epidermal keratins
K14 and K10 (also upregulated here) (55). Whereas K5 protein is
found in all layers in the mouse cornea, its expression is de-
creased in both homozygous and heterozygous mutant mice.
This contrasts with the upregulation of K5 observed in the
human MECD cornea, and this difference may be attributed to
the absence of an orthologue of the human KRT3 gene in the
mouse genome (56). Instead, in WT mice, K12 forms a cytoskel-
eton with K5 (7). Loss of functional K12 expression in the murine
cornea correlates with decreased K5 expression, with a compen-
satory increase in K4 expression as previously observed in K5 null
mice (7). In contrast, human differentiating limbal stem cells
switch from K5/K14 to K3/K12 expression, with K5 expression
not detectable in the central cornea (57,58). Thus, expression of
mutant Leu132Pro keratin K12 in human and mouse corneas
may be considered to result in an alteration of keratins consistent
with an injured tissue attempting to compensate for loss of cyto-
skeletal integrity.
IHC revealed a downregulation in K12 expression in the
humanMECD cornea, whereas in contrast MS data showed an in-
crease in K12, as quantiﬁed by the abundance of K12 peptides in
the MECD cornea. Although K12 peptides may be increased, this
is not a direct correlation to total protein, as K12 may be ex-
pressed and translated before readily undergoing proteolytic pro-
cessing, thus reducing the ability of IHC to detect it. An increase
in proteolysis in theMECD corneawould be expected in response
to UPR (43) and would explain the observed reduction of K12
expression observed by IHC.
In addition, this research is indicative of the UPR having a role
in the pathogenesis of MECD, which constitutes further evidence
of the eye being overly susceptible to cellular stress-related disor-
ders, as has been observed in numerous diseases including FECD
(14–16), keratoconus (59–62), granular corneal dystrophy (63), cat-
aracts (17) and diabetic retinopathy (64,65). However, the exact
UPR pathway activated in MECD remains to be established. This
apparently increased susceptibility to cellular stresses such as
ER stress and oxidative stress could result from the high levels
of UV absorption in the eye (66,67), a known stress-inducing
agent that additionally stimulates protein misfolding and DNA
damage (68). Further research discerning the exact role of these
UPR components in the MECD cornea and the potential role of
UV light in this disorder is still required before a deﬁnitive patho-
mechanism can be elucidated. Although the phenotype observed
in the homozygousmouse ismore severe than that in the hetero-
zygous mouse, similar phenotypic changes in corneal structure,
expression of additional keratins and altered expression of Cas-
pase 12 are apparent in both. This is similar to other previously
reported cornealmousemodels, such as Fuchs, inwhich a homo-
zygous mouse is used as a model for the autosomal dominant,
heterozygous human disease (15). This mouse model will serve
as a test-bed for therapies targeted against corneal stress re-
sponses and, additionally, for other keratinopathies caused by
similar mutations.
Materials and Methods
Design and generation of a transgenic mouse expressing
mutant humanized K12 (L132P)
The targeting vector and mouse were manufactured by Taconic
Artemis (Köln, Germany). The targeting strategy is shown in Fig-
ure 1. The full human KRT12 gene including introns, 5′- and 3′-
UTRs and a 247 bp sequence downstream of the KRT12 3′-UTR
was cloned and the followingmodiﬁcationsmade: the L132Pmu-
tationwas introduced in exon 1; an FRT-ﬂanked neomycin resist-
ance gene (NeoR) was inserted into intron 2; an F3-ﬂanked
puromycin resistance gene (PuroR) was inserted into intron 7; a
FLAG-HA coding sequence (21) was placed immediately before
the termination codon and an MTC (Supplementary Material,
Fig. S1) was inserted within the 3′-UTR of the endogenous
KRT12 gene sequence. The resulting KRT12 transgene was in-
serted in amouse targeting vectorwith a 4.1 kb 5′ short homology
arm (SHA) and a 6.2 kb 3′ long homology arm (LHA), correspond-
ing to the regions ﬂanking themouse Krt12 gene (Fig. 1). TheMTC
contained ∼40 nt including and surrounding the KRT3mutations
c.1525G>A (p.Glu509Lys, E509K), c.1508G>C (p.Arg503Pro, R503P)
and c.1493A>T (p.Glu498Val, E498V) and the KRT12 mutations
c.395T>C (p.Leu132Pro, L132P) and c.404G>C (p.Arg135Thr,
R135T). Regions were arranged sequentially as shown in Supple-
mentary Material, Figure S1, with ﬂanking 5′ NheI and 3′ XhoI re-
striction sites included. Mice were bred to homozygosity with
heterozygote/heterozygote matings to achieve age-matched lit-
termates with all three genotypes. The various genotypes are re-
ferred to as WT = Krt12+/+ (also +/+), heterozygote = Krt12+/hL132P
(also +/−) and homozygote = Krt12hL132P/hL132P (also −/−).
Mouse genotyping
Genomic DNA was extracted from ear biopsies by alkaline lysis
(69). Primers were designed enabling incorporation of a single
PCR three-primer multiplex with one common primer. Genotyp-
ing was achieved using a common forward primer hK12HU.G.1F
(5′-CGA GAG TTG GAACGC AGA GA-3′) in equimolar amounts to
primers hK12HU.G.1R (5′-TCC CTA TCC CCA TTC CTC CC-3′) and
hK12HU.G.2R (5′-CCT GGG TCT GCC TAT CAC AC-3′), the former
detecting the Krt12 allele with a 404 bp product and the latter
the KRT12 allele with a 201 bp product (Supplementary Material,
Fig. S4). The PCR temperature cyclewas as follows: 95°C for 3 min,
35 cycles of 95°C for 15 s, 57°C for 15 s, 72°C for 30 s followed by
5 min at 72°C.
In vivo slit-lamp evaluation of humanized MECD
mouse cornea
Slit-lamp assessment was carried out on mice at 16 weeks (n = 6
per genotype). They were assessed using a portable digital slit
lamp (Hawkeye, Dioptrix, Toulouse, France), with images taken
using a Pentax Optio S60 camera. Both eyes of each mouse were
inspected and imaged. Mouse eyes were also stained with ﬂuor-
escein (Minims Fluorescein Sodium 2%w/v; Bausch & Lomb, Sur-
rey, UK) prior to assessment and images were taken. Eyes were
kept hydrated with Balanced Sterile Saline Solution (Beaver-
Visitec International, Abington, UK) during assessment.
Electron microscopy of humanized MECD mouse cornea
For SEM, the corneal surface was evaluated on one mouse per
genotype at age 7 weeks. Mouse eyes were enucleated, ﬁxed, pro-
cessed and imaged, as described by Fu and colleagues (70).
For TEM of corneal sections, whole mouse eyes were enu-
cleated and immediately immersed in ﬁxative [2.5% glutaralde-
hyde and 4% paraformaldehyde (PFA) in 0.1  sodium cacodylate
buffer, pH7.3], with the backof the eye removedafter 15 min to aid
ﬁxation. Following ﬁxation for 48 h, the corneas were dehydrated
through an ethanol gradient and propylene oxide (71) and embed-
ded in Durcupan resin (Sigma, -Aldrich, Dorset, UK). Ultra-thin
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sections (70 nm)were cut, processed and imaged as described pre-
viously (18) with preliminary observationsmade, followed by con-
ﬁrmation by two blinded individuals.
Preparation of mouse and human tissue
Micewere euthanized by CO2 asphyxiation. For extraction of pro-
tein or RNA,mouse eyeswere immediately enucleated, full thick-
ness corneas dissected as required and placed in 1.5 ml tubes
before being snap-frozen in liquid nitrogen and stored at −80°C.
For histology, whole eyes were enucleated, placed in histology
cassettes (VWR, Lutterworth, UK) and immediately submersed
for 24 h in Davidson’s ﬁxative with ﬁnal concentrations of 36%
ethanol, 12.5% glacial acetic acid and 25% neutral-buffered for-
malin made up in distilled water (72).
Corneal tissue from a 44-year-old female MECD patient, and
known to be heterozygous for the KRT12-Leu132Pro mutation
through previous genotyping (20), was collected after surgery
and separated into two pieces. One portion of the tissue, consist-
ing of all corneal layers, was immediately snap-frozen at −80°C for
proteomic analysis by MS. Control tissue consisting of all corneal
layers was collected postmortem and processed in the sameman-
ner. The second portionwas ﬁxed in 4% PFA for histological exam-
ination. Healthy corneal tissue acquired from the Manchester Eye
Bank was processed in the same way and used as control tissue.
Immunohistochemistry
Afterﬁxation, eyeswere dehydrated through graded alcohol solu-
tions and xylene prior to embedding in parafﬁn wax. Sections of
7 μm were cut and placed on 3-aminopropyltriethoxysilane-
coated glass slides and incubated overnight at 37°C. Slides were
then stored at room temperature until use.
For mouse tissue, IHC was performed using the protocol out-
lined by Leachman et al. (73), with the following modiﬁcations;
all washes were in TBST (TBS containing 0.5% Tween-20) and en-
dogenous peroxidases were blocked with 3% hydrogen peroxide
made up in phosphate-buffered saline (PBS). Immediately prior
to primary antibody incubation, tissues were blocked for 20 min
with 10% serum in PBS. The serum used was from the same host
species inwhich the secondaryantibodieswere raised.Mouse sec-
tions were stained for HA (1:200; C29F4, Cell Signaling Technology,
Hitchin,UK), K5 (1:800; a gift fromE.B. Lane, A-Star Institute, Singa-
pore), K14 (1:400; LL001, Santa Cruz, Biotechnology, Heidelberg,
Germany (70)), K6 [1:500; a gift from Pierre Coulombe (74)], K16
[1:500; a gift from Pierre Coulombe (75)], Caspase 12 (1:200;
ab62484, Abcam, Cambridge, UK) or CHOP (DDIT3) (1:100;
ab179823, Abcam). A horseradish peroxidase (HRP) conjugated
secondary antibody was used to allow visualization of HA, K5,
K14, K6 and K16 proteins. A ﬂuorescein isothiocyanate (FITC)-
conjugated goat anti-rabbit polyclonal antibody (Dako, Glostrup,
Denmark) at a dilution of 1:1000 was used to visualize Caspase
12 and CHOP. These slides were mounted in Ultra-Cruz mounting
medium (Santa Cruz, Heidelberg, Germany) before being imaged
by standard immunoﬂuorescent microscopy. Haematoxylin
and eosin (H&E) staining was performed following standard
protocols.
For human tissue, following rehydration, antigen retrieval
was achieved by proteinase K (Fisher Scientiﬁc, Loughborough,
Uk) (10 μg/ml ﬁnal concentration) at 37°C for 45 min. Non-speciﬁc
antibody binding was blocked by incubation in 5% goat serum,
made up in PBS, for 1 h. Tissue was stained for K12 (1:100), K5
(1:1000), K14 (1:100), K6 (1:200), K16 (1:200), Caspase 12 (1:200) or
CHOP (1:100). All antibody dilutions were made up in 2% goat
serum in PBS. After incubation overnight at 4°C, slides were
washed in PBS, three times for 15 min each, and incubated for
1 h at room temperature with FITC-conjugated goat anti-rabbit
polyclonal antibody (Dako, Glostrup, Denmark) at a dilution of
1:1000 and washed in PBS as before. Slides were mounted in
Ultra-Cruz mounting medium (Santa Cruz, Biotechnology, Hei-
delberg, Germany) before being imaged by immunoﬂuorescent
microscopy.
Preparation of corneal lysates for protein analysis
Lysis buffers A and B were prepared as follows and used in a 1:1
ratio for protein lysis and gel loading. Buffer A consisted of an
aqueous solution containing 1  unbuffered TRIS base and 13%
sodium dodecyl sulphate (SDS). Buffer B consisted of 0.2  DTT,
30% glycerol and 0.002% bromophenol blue to which HCl was
added until the colour changed from blue to orange. Both buffers
were stored at −20°C until use. Frozen corneas were crushed with
a sterile plastic dounce in 100 µl of premixed in-house lysis buf-
fers A and B. Samples were incubated at 70°C for 10 min and so-
nicated for a total of 30 s at 30% ampliﬁcation applied in 10 s
pulses. Cell debris was pelleted at 16 000g for 15 min at 4°C and
the supernatant removed to a fresh tube.
Western blotting
Mouse tissue protein analysis was performed with 5 µl of total
protein lysate per lane. Proteins were resolved on 4–12% BIS/
Tris gels (Life Technologies) on an XCell II (Life Technologies)
system and MOPS-SDS buffer (Life Technologies, Paisley, UK)
and assessed for protein loading by Coomassie blue staining.
Subsequent gel loading volume was normalized on the basis of
total protein and β-actin intensity. Western blotting analysis
was performed as described previously (76) with primary anti-
bodies for K12 (1:1000; Moravian Biotech, Brno, Czech Republic),
HA (1:1000) and β-actin (1:5000; A2228, Sigma).
Western blotting of protein lysates for K5 (1:5000), K14
(1:5000), K6 (1:2000) and K16 (1:2500) was performed using the
same procedure, but a HRP-conjugated secondary antibody was
used and membranes imaged following the manufacturer’s
instructions.
RNA-seq analysis
RNA from frozen corneas of 7–9-week-old mice from each geno-
type (n = 6 individuals for RNA-seq and n = 3 pooled for qPCR) was
extracted after homogenization and lysis using the RNeasy Plus
Minikit together with an on-column DNase digestion (Qiagen
Manchester, UK).
RNA fromsingle corneas (n = 6per genotype)was sequencedby
the Genomic Sequencing Unit (University of Dundee, UK). Librar-
ies were constructed using the TruSeqRNA v2 protocol following
the manufacturer’s instructions (Illumina, Saffron Walden, UK)
and were normalized to 10 n and pooled in three sets of six.
Each pool contained two WT samples, two heterozygote samples
and two homozygote samples. Each sample pool was sequenced
using a HiSeq2000 (Illumina) as paired-end 100 bp reads.
For RNA-seq data analysis, reads were aligned with STAR
(version 2.3.0e_r291) against the mouse reference genome
(Ensembl release 74), with the following parameters: outFilter-
MultimapNmax 2—outFilterMismatchNmax 5—outFilterType
BySJout—outSJﬁlterIntronMaxVsReadN 5000 10 000 15 000 20 000.
Approximately 87% of reads were found to align. Aligned reads
were annotated to genes with htseq-count (version 0.5.4p5) in
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‘union’mode, referenced toEnsembl (release 74) gene annotations.
The resulting gene read counts were used to determine dif-
ferentially expressed genes. All 18 samples were imported in R
(v. 3.0.2), and any gene with fewer than 36 reads (i.e. two per sam-
ple) in total was excluded from further analysis (leaving 16 845
genes). edgeR (v. 3.4.0) was used in GLM mode across all samples
to identify all differentially expressed genes with false discovery
rate-adjusted P < 0.05 in the WT versus heterozygous and WT
versus homozygous comparisons.
qRT-PCR
An equimolar quantity of VIC-labelled mGAPDH primers and
probes (Applied Biosystems, assay no. 4352339E) was added as
an internal control into each keratin qPCR. RNAwas reverse-tran-
scribed according to the manufacturer’s protocol (High Capacity
Reverse Transcription kit, Life Technologies). Krt12/KRT12 qPCR
reactions (perfeCTa® qPCR toughmix; Quanta Biosciences,
Gaithersburg, MD, USA) contained cDNA equivalent to 1.25 ng/µl
total RNA. qPCR reactions for other keratins (TaqMan Universal
Mastermix II, Life Technologies) contained cDNA equivalent to
1.8 ng/µl. ATaqMan 7900HTmachine (Applied Biosystems Paisley,
UK) was used for quantiﬁcation of triplicate samples using the
ΔΔCt method (77).
TUNEL assay and quantiﬁcation
ATUNEL assay to identify apoptotic cells was performed on sec-
tions containing ocular tissue from WT, heterozygous or homo-
zygous MECD mice. After deparafﬁnization, rehydration and
antigen retrieval, as described previously, apoptotic cells were
stained using the In Situ Cell Death Detection kit (Fluorescein;
Roche, Burgess Hill, Surrey, UK) following the manufacturer’s
instructions. Slides were mounted and imaged using standard
ﬂuorescent microscopy. Corneas from three mice of each geno-
typewere sectioned, and three images were taken and quantiﬁed
for each cornea. The numbers of live and apoptotic cells were de-
termined from images taken from the central corneas. The pro-
portion of apoptotic cells was calculated for each section by
dividing the number of apoptotic cells by DAPI-stained cells.
Sample preparation for LC-MS/MS—in-solution digest
Patient and control tissues were lyophilized for 2 h using a vac-
uum concentrator and ground into powder under liquid nitrogen
using a pestle andmotor. In total, 1.2 mg of each tissue was trea-
ted with 0.66  CNBr in 70% triﬂuoroacetic acid overnight at 23°C.
The samples were lyophilized and resuspended in 6  urea in
0.2  Tris–HCl, pH 8.3, before being reduced in 5 mm dithiothrei-
tol (DTT) for 30 min and then alkylated in 15 mm iodoacetamide
for 30 min. Samples were digested with Lys-C protease (Sigma,
-Aldrich) 1:1000 w/w for 6 h at 37°C and then diluted four times
using 0.1  Tris–HCl, pH 8.3, followed by a second digestion
step overnight with 1:50 w/w sequencing grade-modiﬁed trypsin
(Sigma, -Aldrich) at 37°C for 16 h. The samples were desalted
using POROS 50 R2 RP column material (Applied Biosystems)
packed in GELoader Tips (Eppendorf, Stevenage, UK).
Liquid chromatography (LC)-MS/MS analysis
LC-MS/MS analyses were performed on an EASY-nLC II system
(Thermo Fisher Scientiﬁc, Paisley, UK) connected to a TripleTOF
5600 +mass spectrometer (AB SCIEX, Copenhagen, Denmark)
equipped with a NanoSpray III source (AB SCIEX) and operated
under Analyst TF 1.6.0 control. The CNBr and trypsin-cleaved
samples were dissolved in 0.1% formic acid, injected and trapped
on an in-house packed trap column (2 cm× 100 μm i.d.) using RP
ReproSil-Pur C18-AQ 3 μm resin (Dr Maisch GmbH, Ammerbuch-
Entringen, Germany). Peptides were eluted from the trap column
and separated on a 15 cm analytical column (75 μm i.d.), pulled
and packed in-house with RP ReproSil-Pur C18-AQ 3 μm resin
(Dr Maisch GmbH) and sprayed directly into the mass spectrom-
eter. Peptides were eluted at a ﬂow rate of 250 nl/min using a
50 min gradient from 5 to 35% phase B (0.1% formic acid and
90% acetonitrile). The acquisition method used for the extracted
ion chromatogram (XIC) quantiﬁcation was set up as an informa-
tion-dependent acquisition experiment collecting up to 25 MS/
MS spectra in each 1.6 s cycle using an exclusion window of
12 s. The Meesmann and control corneal samples were each
run in triplicate on the mass spectrometer.
Protein quantitation
Rawdata from the LC-MS/MSwere converted tomgf format using
AB SCIEX MS Data Converter beta 1.1 and the ‘proteinpilot mgf’
parameters, and peptides were searched using an in-house Mas-
cot search engine (Matrix Science, London, UK; version: 2.5.0)
and queried against the Swiss-Prot database (version: 2015_09).
CNBr + trypsin was selected as the digestion enzyme allowing
one missed cleavage. Carbamidomethyl was entered as a ﬁxed
modiﬁcation, whereas hydrozylation of proline, oxidation of me-
thionine and C-terminal conversion of methionine to homoser-
ine and homoserine lactone by CNBr were used as variable
modiﬁcations. The data were searched with a mass tolerance of
the precursor and product ions of 10 ppm and 0.2 Da using ESI-
QUAD-TOF as the instrument setting. All searches had a P < 0.01
applied and an expected value of 0.005. Only protein hits identi-
ﬁed by a minimum of two peptides with Mascot ion scores above
30were considered for further analyses. In addition, porcine tryp-
tic peptides identical to human peptides were removed as por-
cine trypsin was used during the processing of the samples.
All data were imported and processed in MS Data Miner
v. 1.3.0 (78). Proteinswere arranged on the basis of their exponen-
tiallymodiﬁed Protein Abundance Index values (emPAI). Relative
abundancewas termed as the emPAI value for each protein in the
sample divided by the sum of the emPAI values of all proteins
present within the tissue specimens.
Statistics
All error bars indicate the standard error of themean across sam-
ples of the same biological signiﬁcance. A one-way analysis of
variance was performed to calculate signiﬁcance in the differ-
ences in keratin protein expression in mouse corneas, assessed
by immunoblotting. In all other cases, a Student’s t-test was
used to calculate signiﬁcance; P < 0.05 was deemed to be
signiﬁcant (*P < 0.05, **P < 0.01 and ***P < 0.001).
Study approval
For all human tissues, ethical issues were handled according to
Danish healthcare law and in accordance with the local Ethics
Committee and national health authorities. All work was carried
out in accordancewith theDeclaration ofHelsinki. Informed con-
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study.
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